跳至主要内容
临床试验/NCT02393846
NCT02393846已完成4 期

Comparison of Topical Dexketoprofen Versus Placebo in Patients Presented With Ankle Sprain to the Emergency Department: A Randomised Placebo Controlled Trial

Akdeniz University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Visual analogue scale

研究概览

简要总结

The aim of this study is to analyse the effect of ketoprofen gel in patients presented with ankle sprain to the emergency department.

详细描述

Patients, 18-65 years old, presented with ankle sprain are enrolled into the study. Pain over 24 hours, pain intensity lower than 40 mm, allergy to the study drug, drug alcohol abuse and pregnancy or breastfeeding are the exclusion criteria. The study interventions are 2 gr of 2.5% ketoprofen gel versus placebo applied to the sprain area. The study drugs are identical in colour, form and smelling. After an eligible patient presented to the ED, the drug number from an opaque bag is determined by a nurse and then another nurse applies the study drug to the patient. Physicians, nurses and patients are blinded to the study drug. Pain intensity of patients is measured by visual analogue scale at baseline, 15th and 30th minutes after the administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient presented with ankle sprain to the emergency department.
  • Patients between 18-65 years old.

排除标准

  • Pain over 24 hours,
  • Pain intensity lower than 40 mm,
  • allergy to the study drug,
  • drug alcohol abuse
  • pregnancy or breastfeeding are the exclusion criteria.

研究组 & 干预措施

ketoprofen

Experimental

Topical ketoprofen (gel) is the experimental drug that is applied to the ankle in a dose of 2 gr.

干预措施: Ketoprofen gel (Drug)

Placebo

Placebo Comparator

Topical placebo (gel) is identical in colour, form and smell with the ketoprofen gel.

干预措施: Placebo (Drug)

结局指标

主要结局

Visual analogue scale

时间窗: 30 minutes

Pain intensity is measured by visual analogue scale at baseline, 15 and 30 minutes after the administration.

次要结局

  • Adverse effects(30 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cenker Eken

Associate Professor

Akdeniz University

研究点 (1)

Loading locations...

相似试验